FdaApplication
ANDA 218180
Identifiers
- fda_app_no: ANDA218180
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2025-01-28 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE;ORAL |
4 products